LARIMAR THERAPEUTICS, INC. (LRMR) Operating cash flow 2016–2025
LARIMAR THERAPEUTICS, INC. (LRMR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$113.2MFY2025 · since FY2016: -$52.0M → -$113.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$113.2M | -60.0% |
| FY2024 | -$70.8M | -111.5% |
| FY2023 | -$33.5M | -21.4% |
| FY2022 | -$27.6M | +34.5% |
| FY2021 | -$42.1M | +0.2% |
| FY2020 | -$42.2M | -85.9% |
| FY2019 | -$22.7M | +55.9% |
| FY2018 | -$51.5M | -17.6% |
| FY2017 | -$43.8M | +15.8% |
| FY2016 | -$52.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LRMR financial trends
LRMR RevenueLRMR Net incomeLRMR Net marginLRMR Gross profitLRMR Gross marginLRMR Operating incomeLRMR Operating marginLRMR Free cash flowLRMR Capital expendituresLRMR Return on equityLRMR Stock buybacksLRMR Dividends paidLRMR Total assetsLRMR Total liabilitiesLRMR Shareholders’ equityLRMR overview →